as of 01-06-2026 4:00pm EST
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WORCESTER |
| Market Cap: | 4.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 90.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.89 - $13.29 | Next Earning Date: | 11-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$0.96
Shares
247
Total Value
$237.61
Owned After
145
SEC Form 4
Director
Avg Cost/Share
$0.95
Shares
4
Total Value
$3.82
Owned After
375
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Jin David | MBIO | Director | Dec 30, 2025 | Buy | $0.96 | 247 | $237.61 | 286 | |
| Herskowitz Neil | MBIO | Director | Dec 30, 2025 | Sell | $0.96 | 247 | $237.61 | 145 | |
| Chill Adam J. | MBIO | Director | Dec 30, 2025 | Sell | $0.95 | 4 | $3.82 | 375 |
See how MBIO stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "MBIO Mustang Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.